Riskpilot← Back to searchSign inGet full accessNORSK BIOAKVA AS
ASActiveOrg 968703250Garden 12, 5690 LundegrendMarine aquaculture · NACE 0321Est. 19940 employees
Revenue 2024
NOK 0
EBITDA margin
—
+3% vs 2023
Equity ratio
95.9%
Financial strength
Net profit 2024
NOK 9,2M
+70% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -372K | +3% |
| Net profit | NOK 9,2M | +70% |
| Total assets | NOK 53,6M | +9% |
| Equity | NOK 51,4M | +17% |
| Employees | 0 | — |
Legal name
NORSK BIOAKVA AS
Org number
968703250
Legal form
Aksjeselskap
NACE code
0321 · Marine aquaculture
Founded
4. februar 1994
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Forproduksjon og salg av konsulent- og tekniske tjenester tilknyttet slik virksomhet, produksjon av akvakulturprodukter samt hva dermed står i forbindelse. Selskapet kan forøvrig drive produksjon, kjøp og salg av produkter eller tjenester tilknyttet primærnæringene. Selskapet kan foreta investeringer i verdipapirer av enhver art og i fast eiendom samt hva dermed står i forbindelse.
Address
Garden 12, 5690 Lundegrend
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −68 | −242 | −361 | −382 | −372 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −68 | −242 | −361 | −382 | −372 |
| Net financials | 4 452 | 5 331 | −1 074 | 5 767 | 9 528 |
| Profit before tax | 4 384 | 5 089 | −1 435 | 5 385 | 9 156 |
| Tax | 26 | −28 | 28 | −0 | −0 |
| Net profit | 4 358 | 5 117 | −1 463 | 5 385 | 9 156 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 44 536 | 47 647 | 46 404 | 49 045 | 53 566 |
| Equity | 41 951 | 39 988 | 38 525 | 43 910 | 51 352 |
| Long-term debt | 2 000 | 1 303 | 2 028 | 2 325 | 320 |
| Short-term debt | 585 | 6 357 | 5 851 | 2 810 | 1 894 |
| Total debt | 2 585 | 7 660 | 7 879 | 5 135 | 2 214 |
EBITDA margin
-37152700.0%
This company
15.8%
Market median
-235143771% vs market
20202024
Equity ratio
95.9%
This company
38.2%
Market median
+151% vs market
20202024
Return on equity
17.8%
This company
18.4%
Market median
+3% vs market
20202024
Net profit margin
915598800.0%
This company
8.1%
Market median
+11303688789% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2014 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 7% | 7% | 2022 | |
| Individual | 7% | 7% | 2024 | |
| Individual | 7% | 7% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NORSK BIOAKVA AS 
BIOAKVA CONSULT ASBoard members of NORSK BIOAKVA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Merete Fjeldstad | Board of Directors | 0 companies |
| Einar Wathne | Chairman | 0 companies |